Immunotherapy Yields ‘Dramatic’ Response Rates in Relapsed Mesothelioma – Cancer Network
Cancer Network |
Immunotherapy Yields 'Dramatic' Response Rates in Relapsed Mesothelioma
Cancer Network CHICAGO—Immunotherapy may represent an effective new treatment approach for relapsed mesothelioma patients, according to a new study. Anti–programmed death-1 (PD-1) immunotherapy may have activity as second- or third-line therapy in malignant … |
